Volume 5, Number 5—October 1999
Research
Tracking Drug-Resistant Streptococcus pneumoniae in Oregon: An Alternative Surveillance Method
Table 2
Streptococcus pneumoniae susceptibility to cefotaxime, trimethoprim-sulfamethoxazole, and erythromycin, by two surveillance methods, Portland, Oregon, 1996
Cefotaxime |
Trimethoprim-Sulfamethoxazole |
Erythromycin |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospital | Active surveillance |
Antibiograms |
Active surveillance |
Antiobiograms |
Active surveillance |
Antiobiograms |
||||||||||||
No. isolates | Susceptible |
No. isolates | Susceptible | No. isolates | Susceptible |
No. isolates | Susceptible | No. isolates | Susceptible |
No. isolates | Susceptible |
|||||||
N | % | N | % | N | % | N | % | N | % | N | % | |||||||
A | a | b | a | b | a | b | ||||||||||||
B | 34 | 32 | 94 | 10 | 8 | 80 | 34 | 26 | 76 | b | 34 | 33 | 97 | 134 | 126 | 94 | ||
C | 59 | 54 | 92 | 274 | 255 | 93 | 59 | 49 | 83 | 274 | 230 | 84 | 59 | 57 | 97 | 274 | 230 | 84 |
D | 6 | 4 | 67 | 120 | 112 | 93 | 6 | 3 | 50 | 6 | 5 | 83 | 120 | 88 | 73 | |||
E | 12 | 12 | 100 | b | 12 | 9 | 75 | 16 | 13 | 81 | 12 | 12 | 100 | 42 | 39 | 93 | ||
F | a | 61 | 59 | 97 | a | b | a | 61 | 56 | 92 | ||||||||
G | 33 | 31 | 94 | 110 | 105 | 95 | 33 | 27 | 82 | b | 33 | 30 | 91 | 110 | 100 | 91 | ||
H | 11 | 11 | 100 | - | 11 | 10 | 91 | b | 11 | 11 | 100 | b | ||||||
I | 8 | 7 | 88 | - | 8 | 6 | 75 | b | 8 | 8 | 100 | b | ||||||
J | 7 | 6 | 86 | - | 7 | 5 | 71 | 10 | 8 | 80 | 7 | 6 | 86 | 10 | 10 | 100 | ||
K | 6 | 6 | 100 | - | 6 | 4 | 67 | b | 6 | 5 | 83 | b | ||||||
L |
2 |
2 |
100 |
- |
2 |
2 |
100 |
b |
2 |
2 |
100 |
b |
||||||
Total | 178 | 165 | 93 | 575 | 539 | 94 | 178 | 141 | 79 | 300 | 251 | 84 | 178 | 169 | 95 | 751 | 649 | 86 |
aIsolates submitted to the Oregon Public Health Laboratory.
bAntibiogram data not available from hospital.
Page created: December 15, 2010
Page updated: December 15, 2010
Page reviewed: December 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.